Transducin-like Enhancer of split (TLE) 1 is a mammalian transcriptional corepressor homologous to Drosophila Groucho. In Drosophila, Groucho acts together with bHLH proteins of the Hairy/Enhancer of split (HES) family to negatively regulate neuronal differentiation. Loss of the functions of Groucho or HES proteins results in supernumerary central and peripheral neurons. This suggests that mammalian TLE/ Groucho family members may also be involved in the regulation of neuronal differentiation. Consistent with this possibility, TLE1 is expressed in proliferating neural progenitor cells of the central nervous system, but its expression is transiently down-regulated in newly generated postmitotic neurons. Based on these observations, we investigated whether persistent TLE1 expression in postmitotic neurons would perturb the normal course of neuronal development. Transgenic mice were derived in which the human TLE1 gene is regulated by the promoter of the Ta 1 a-tubulin gene, which is exclusively expressed in postmitotic neurons. In these mice, constitutive expression of TLE1 inhibits neuronal development in the embryonic forebrain leading to increased apoptosis and neuronal loss in the ventral and dorsal telencephalon. These results provide the ®rst direct evidence that TLE1 is an important negative regulator of postmitotic neuronal differentiation in the mammalian central nervous system. q
Introduction
During the genesis of the mammalian central nervous system, neural precursor cells located in the ventricular zone lining the central canal and brain ventricles undergo proliferation and ultimately exit the cell cycle and differentiate into neurons in response to both extrinsic and intrinsic cues. The commitment of neural progenitor cells to the neuronal fate and their subsequent differentiation into mature neurons are controlled by mechanisms involving the antagonistic activities of separate families of DNA-binding transcription factors containing the basic helix-loophelix (bHLH) motif. One group comprises evolutionarily conserved transcriptional activators that act as positive regulators of neuronal differentiation. Members of this family of bHLH factors include, among others, several homologous proteins belonging to the Neurogenin-, Ash-, and NeuroD subgroups (Guillemot et al., 1993; Lee et al., 1995; Ma et al., 1996) . These proteins are structurally and functionally related to a number of Drosophila bHLH factors that promote neuronal differentiation (reviewed in Campos-Ortega, 1993; Jan and Jan, 1994) and are collectively referred to as the proneural proteins. Similar to their Drosophila counterparts, ectopic expression of vertebrate proneural proteins results in the differentiation of supernumerary neurons, while mutations that disrupt their functions cause central and peripheral neuronal loss (Lee et al., 1995; Ma et al., 1996; Fode et al., 1998; Ma et al., 1998) .
A second family of bHLH factors involved in the regulation of mammalian neurogenesis comprises proteins that act as transcriptional repressors. These include a number of factors homologous to the Drosophila Hairy/Enhancer of split (HES) family of DNA-binding proteins (Akazawa et al., 1992; Delidakis and Artavanis-Tsakonas, 1992; Sasai et al., 1992; Ishibashi et al., 1993; Dawson et al., 1995) . In both invertebrates and vertebrates, HES proteins negatively regulate neuronal differentiation by inhibiting the function of genes that promote the neuronal fate, including proneural genes. For instance, targeted disruption by homologous recombination of the mouse HES family member, HES-1, results in premature embryonic central neurogenesis and up-regulated expression of the proneural gene, Mash-1 (Ishibashi et al., 1995) . Conversely, persistent expression of HES-1 in the cerebral cortex of developing mouse embryos causes inhibition of neuronal differentiation (Ishibashi et al., 1994) .
A number of ®ndings indicate that the neural functions of Drosophila HES proteins are mediated by the transcriptional corepressor, Groucho. Genetic studies show that loss of groucho function causes the same neural phenotypes as those associated with loss-of-function alleles of HES genes, namely an overproduction of neurons at the expense of epidermis (Delidakis et al., 1991; Schrons et al., 1992; Paroush et al., 1994; Heitzler et al., 1996) . Moreover, Groucho and HES proteins physically interact with each other (Paroush et al., 1994; Fisher et al., 1996) , and mutations that render HES proteins incapable of interacting with Groucho interfere with their ability to mediate transcriptional repression (Fisher et al., 1996) . These ®ndings indicate that Drosophila HES and Groucho proteins interact with each other to form transcription repression complexes that act as negative regulators of neuronal differentiation. Within these complexes, HES proteins provide a speci®c DNA-binding function while Groucho provides a transcription repression function.
Several mammalian homologues of Drosophila Groucho, designated as the transducin-like Enhancer of split (TLE) or Groucho-related 1 through 4 proteins (hereafter referred to as TLE1±4) (Stifani et al., 1992; Roose et al., 1998) , have also been implicated in mechanisms underlying neuronal development. In particular, TLE1 is expressed in mitotic neural progenitor cells of the central nervous system, but its expression is then down-regulated when new postmitotic neurons are born. This decrease is transient, however, as TLE1 expression is reactivated in more mature neurons that have reached their destinations (Dehni et al., 1995; Yao et al., 1998) . The down-regulation of TLE1 expression during early stages of postmitotic neuronal differentiation suggests that TLE1 may be a negative regulator of neuronal differentiation, like Groucho in Drosophila. This hypothesis is consistent with the previous demonstration that TLE1 is a transcriptional repressor that interacts with mammalian HES factors (Grbavec et al., 1998) , suggesting that complexes of HES and TLE1 proteins may perform transcription repression functions involved in the negative regulation of mammalian neurogenesis. An involvement of TLE1 in nervous system development is also suggested by the ®nding that the C. elegans groucho-related gene, unc-37, controls the speci®cation of motor neuron identity during nematode development (P¯ugrad et al., 1997) . The C-terminal domains of UNC-37 and human TLE1 are functionally interchangeable during motor neuron differentiation in C. elegans, suggesting that TLE/Groucho family members may perform evolutionarily conserved roles during neuronal development.
Here we describe studies in which the normal expression pattern of TLE1 during neuronal differentiation was altered in transgenic mice to examine the effects associated with persistent expression of this protein during postmitotic neuronal differentiation. Our results demonstrate that constitutive TLE1 expression inhibits neuronal development in the embryonic forebrain, leading to a loss of cortical and striatal neurons of the telencephalon. These ®ndings demonstrate that TLE1 acts as a negative regulator of neuronal differentiation in mammals.
Results

Generation of Ta 1:TLE1 transgenic mice
To investigate the involvement of TLE1 in the regulation of mammalian neuronal development, we sought to examine the effect of altering the normal expression pattern of this protein in postmitotic neurons. Transgenic mice were generated expressing the human TLE1 gene under the control of the neuron-speci®c Ta1 a-tubulin (Ta1) promoter. This promoter is silent in neural progenitor cells and is activated after terminal mitosis (Majdan et al., 1997; Gloster et al., 1999) . Because the expression of TLE1 is normally downregulated in newly born neurons concomitant with the activation of the Ta1 promoter (Dehni et al., 1995; Yao et al., 1998; Gloster et al., 1999) , we reasoned that the expression of a Ta 1:TLE1 transgene would cause a constitutive expression of TLE1 in postmitotic neurons. Pronuclear stage embryos were injected with the construct diagrammed in Fig. 1a . Four primary transgenic animals were identi®ed by Southern blotting analysis and designated as TG8, TG24, TG26, and TG29, respectively (Fig. 1b) . Lines were derived from all four and mice TG24 and TG26 were analyzed in detail.
Developmental defects in the forebrain of Ta 1:TLE1 transgenic embryos
Although heterozygous Ta1:TLE1 transgenic mice were viable and fertile, subtle brain abnormalities could be detected as early as gestational day 13 (E13). In both lines TG24 and TG26, the forebrain of Ta1:TLE1 transgenic embryos was reduced in size and was somewhat¯attened compared to control littermates. Histological analysis of serial horizontal brain sections revealed that the telencephalic vesicles of the transgenic embryos were smaller and sometimes unevenly developed (Fig. 2a±f) . To exclude the possibility that our examination might be confounded by the fact that differentiation in the telencephalon proceeds in a rostral to caudal direction, horizontal sections through serial planes of the forebrain of control embryos were routinely compared to slightly more rostral sections through the forebrain of transgenic embryos. This approach revealed that the abnormal development of the telencephalic vesicles of the transgenic embryos was not limited to a particular rostrocaudal position (see for example Fig. 2a±d ). Moreover, it showed that the developing cortical plate of the telencephalon of transgenic embryos was thinner than that of control littermates. The cortical plate contains differentiating neurons derived from neural precursor cells located in the ventricular zone lining the lateral ventricles (McConnell, 1995) . During development, the thickness of the cortical plate increases as successive waves of neurons are born at the ventricular/intermediate zone border and migrate to their more super®cial ®nal destinations. Ta1:TLE1 transgenic embryos appeared to have fewer such cortical neurons than their control littermates, suggesting that constitutive TLE1 expression perturbs neuronal development in the dorsal telencephalon (cf. Fig. 2a,b ,e,f). In addition, Ta1:TLE1 embryos displayed signi®cantly smaller ganglionic eminences, which are the primordia of the basal ganglia (cf. Fig. 2a±d ). The diencephalon also was smaller in transgenic embryos (Fig. 2a±d) . As a result, the telencephalon of transgenic embryos was located closer to the level of the eyes than that of control embryos (see for example Fig. 2c, d) . Although the midbrain and hindbrain were not obviously affected, in occasional Ta1:TLE1 embryos the pons appeared somewhat smaller compared to controls. The development of the spinal cord and the peripheral nervous system appeared normal (data not shown), even though the Ta1 promoter is activated in these tissues (Majdan et al., 1997; Gloster et al., 1999) . Together, these ®ndings show that expression of the Ta 1:TLE1 transgene perturbs the development of the forebrain, particularly the ventral and dorsal telencephalon.
To determine how the forebrain phenotype in Ta1:TLE1 transgenic embryos correlated with altered expression of TLE1, we ®rst performed immunohistochemical studies with anti-TLE1 antibodies. In the telencephalic vesicles of (,5 .0 mg/lane) extracted from tail biopsies from the indicated transgenic mice (lanes 1±4) or non-transgenic littermates (lanes 5 and 6) was digested with EcoRI and subjected to Southern blotting analysis using a ,500 bp probe corresponding to the region encoding amino acids 260 through 435 of human TLE1. Transgenic animals displayed a diagnostic hybridization to a ,4.6-kb restriction fragment, in agreement with the predicted size of a fragment derived from the integration of a head-to-tail multimer of the transgene. DNA size markers (in kb) are indicated.
control embryos, TLE1 expression marked cells of the ventricular zone and, more prominently, postmitotic neurons located in the super®cial layers of the cortical plate (Fig.  3a ,c,e; see arrow in e) (Dehni et al., 1995; Yao et al., 1998) . In contrast, little or no expression was observed in the intermediate zone where migrating neurons are located (Fig. 3a, c,e). This pattern was markedly altered in Ta1:TLE1 embryos, where TLE1 immunoreactivity was observed in the ventricular and the intermediate zones of the telencephalic vesicles, whereas little expression was detected in the super®cial layers of the cortical plate (Fig. 3b,d ,f). To con®rm that Fig. 2 . Histological analysis of control and Ta1:TLE1 transgenic embryos. Either E13 (a±d) or E14.5 (e,f) embryos were collected, ®xed in 4% paraformaldehyde, and embedded in paraf®n. Horizontal sections through the brain of either control (a,c,e) or transgenic (b,d,f) embryos from line TG26 were analyzed for histological abnormalities by staining with hematoxylin and eosin. To take into account the fact that differentiation in the telencephalon proceeds in a rostral to caudal direction, sections through the forebrain of control embryos were compared only to slightly more rostral sections through the forebrain of transgenic embryos (note how in each pair the plane of the hindbrain present on the transgenic section is slightly more caudal than the hindbrain plane present on the control section). Both the telencephalic vesicles (tv) and ganglionic eminences (ge) of transgenic embryos (b,d,f) are smaller than those of control embryos (a,c,e). The developing cortical plate is thinner in Ta1:TLE1 embryos (see arrows in (a,b)). The diencephalon (d) also appears smaller in transgenic embryos (cf. a±d). d, diencephalon; fv, fourth ventricle; ge, ganglionic eminence; m, medulla oblongata; mv, mesencephalic vesicle; p, pons; rm, roof of midbrain; th, thalamus; tr, trigeminal ganglion; tv, telencephalic vesicle. Scale bars: (a±d) 250 mm; (e,f) 280 mm. this alteration of TLE1 expression was correlated with the expression of the Ta 1:TLE1 transgene, we subjected matching sections to in situ hybridization studies with a riboprobe speci®c for the 5 H region of the human TLE1 gene. While no labeling was detected in control embryos (Fig. 3g ), in Ta1:TLE1 embryos hybridization signals were readily detected in cells located in the intermediate zone, consistent with the activation of the Ta1 promoter in postmitotic neurons (Fig. 3h) . Weaker labeling could also be observed in the more super®cial layers of the telencephalon, where the Ta1 promoter is normally robustly activated (Gloster et al., 1999) and TLE1 is normally expressed. Thus, transgene expression altered the expression pattern of TLE1 in the telencephalon by leading to a continuation of TLE1 expression in newly born and migrating postmitotic neurons. This situation was correlated with a reduction of TLE1 protein expression in the super®cial cortical layers occupied by more developmentally mature neurons (Fig. 3f ). These observations suggest that postmitotic neurons that constitutively express TLE1 fail to reach their normal destinations, presumably as a result of cell death.
Neuronal loss in the telencephalon of Ta 1:TLE1 transgenic embryos
To con®rm that the forebrain phenotype observed in the transgenic embryos was due to neuronal loss, we ®rst conducted immunohistochemical studies using a monoclonal antibody against the pan-neuronal marker protein, type-III btubulin (Geisert and Frankfurter, 1989) . Comparison of sections from transgenic and control littermates revealed that Ta1:TLE1 embryos displayed a reduction in the number of type-III b-tubulin-positive cells present in the developing cortical plate of the dorsal telencephalon (Fig. 4a±d ). This anomaly was evident both in the frontal and the lateral regions of the telencephalic vesicles and throughout their rostrocaudal extent (cf. Fig. 4a ,c,e,f). Decreased type-III btubulin immunoreactivity was also observed in the ganglionic eminences of the ventral telencephalon (cf. Fig. 4e,f) . These results, together with the decrease in TLE1-expressing cells observed in the cortical plate of transgenic embryos (see Fig. 3a±f above) , strongly suggest that the expression of the Ta 1:TLE1 transgene leads to a loss of neuronal cells.
In an attempt to quantitate the extent of this neuronal loss, we performed Western blotting analysis of extracts derived from dissected heads of transgenic and control embryos obtained from the same females. In both lines TG24 and TG26, samples from transgenic embryos contained detectably higher levels of the ,95-kDa TLE1 protein than nontransgenic control littermates (Fig. 5a,f) . In contrast, the expression of several neuronal proteins was reduced in transgenic embryos. The TLE4 protein, which is normally robustly activated in postmitotic cortical neurons (Yao et al., 1998) , was markedly reduced (Fig. 5b) . The expression of NeuroD, a neuronal protein known to be highly expressed in the dorsal telencephalon at early stages of postmitotic neuronal differentiation (Lee et al., 1995; Sommer et al., 1996; Schwab et al., 1998) , was also decreased in transgenic embryos (Fig. 5c,h) . Moreover, the 180-kDa form of the neural cell adhesion molecule (NCAM), the isoform expressed almost exclusively in neurons (Persohn et al., 1989) , was also reduced (Fig. 5g, see arrow) . In contrast, we observed no similar changes in the expression of the 140-kDa NCAM isoform that is present in both neuronal and non-neuronal cells (Persohn et al., 1989) (Fig. 5g, see  arrowhead) and the radial glial marker protein recognized by monoclonal antibody 3CB2 (Prada et al., 1995) (Fig. 5i) .
Contrary to the changes observed in postmitotic neuronal markers, proteins that are expressed in proliferating neural progenitor cells of the telencephalon in which the Ta1 promoter is silent were unaltered. These included the winged helix transcription factor, brain factor 1 (BF-1), whose expression is restricted to proliferating neuroepithelial cells of the telencephalon and the nasal half of the retina and optic stalk (Xuan et al., 1995) (Fig. 5d) , and the paired domain-containing protein, Pax-6, which is expressed in neural progenitor cells of the dorsal telencephalon (Walther and Gruss, 1991; Xuan et al., 1995) (Fig. 5e) . Expression of the neurogenin1 and -2 genes was also unaltered (data not shown). Similarly, analysis of the expression of the cellcycle protein, p55Cdc, a general marker of proliferating cells (Weinstein, 1997) , also revealed no detectable changes (data not shown).
Our combined observations suggest that the neuronal loss observed in the transgenic embryos is not due to an inhibition or delay in the transition of progenitor cells to the postmitotic state, because this situation should result in an increase in the expression of telencephalic neural progenitor cell markers like BF-1 and Pax-6. Instead, it appears that postmitotic neurons are initially speci®ed properly but then fail to reach their ®nal destinations and fully differentiate. An increase in postmitotic cell death might account for the overall reduction in postmitotic neurons. To examine this possibility further, sections through the forebrain of transgenic and control embryos were analyzed by TUNEL labeling. Our studies revealed a roughly two-fold augmentation in the total number of apoptotic cells in the telencephalon of Ta1:TLE1 transgenic embryos (Fig. 6 ). This change likely re¯ected a larger increase in the relative number of apoptotic cells, given that the overall number of cells present in the cortical plate and ganglionic eminences of the transgenic embryos was smaller than that of control samples (see Figs. 2±4 ). These observations suggest that constitutive expression of TLE1 in postmitotic neurons promotes neuronal apoptosis.
Discussion
TLE1 is a negative regulator of neuronal development in the mammalian forebrain
The present studies provide the ®rst in vivo demonstration that TLE/Groucho family members are involved in the regulation of mammalian neuronal differentiation. Our ®nd-ings show that the growth of both the dorsal and the ventral telencephalon is markedly reduced in Ta1:TLE1 transgenic embryos, resulting in a phenotype characterized by smaller cerebral hemispheres. This developmental perturbation is the consequence of a loss of cortical and striatal neurons. Taken together with the previous demonstration that TLE1 shares conserved molecular properties with Drosophila Groucho (Husain et al., 1996; Palaparti et al., 1997; Grbavec et al., 1998) and that Groucho acts as a negative regulator of insect neurogenesis (Delidakis et al., 1991; Schrons et al., 1992; Heitzler et al., 1996) , these ®ndings establish an important role for TLE1 in mechanisms that negatively regulate mammalian neuronal differentiation in the telencephalon.
Given the fact that the Ta 1:TLE1 transgene is not expressed in neural progenitor cells, where the Ta1 promoter is not activated (Gloster et al., 1999) , it is unlikely that the phenotype caused by the constitutive expression of TLE1 is due to an inhibition of the transition of neural progenitor cells to the postmitotic state. This situation would be expected to result in an expansion of the neural progenitor cell population, a possibility that is not consistent with our ®nding that the expression of markers of proliferating cells of the telencephalic ventricular zone is unaltered in Ta1:TLE1 embryos. Instead, we propose that postmitotic neurons are properly speci®ed in transgenic embryos but are then inhibited from progressing towards their fully differentiated state during subsequent stages of postmitotic development. Neuronal cell death may then follow as a secondary event. Although it is not known why cells that are inhibited from developing should die rather than remain in a poorly differentiated state, it is conceivable that they are incapable of transducing positional clues and that death may result from the activation of apoptotic mechanisms. This possibility is suggested by a number of previous studies showing a correlation between inhibition of early stages of neuronal differentiation and cell death. For instance, neuronal death was demonstrated in the nervous system of mice in which the retinoblastoma (Rb) gene has been inactivated by homologous recombination. Rb 2/2 neuronal progenitor cells can initiate differentiation (i.e. they activate expression of early neuronal marker proteins) but are unable to continue their development and undergo apoptosis (Slack et al., 1998) . Similarly, inhibition of neuronal differentiation and increased cell death were reported in the nervous system of mice in which the mammalian proneural gene, Mash-1, had been inactivated by homologous recombination (Guillemot et al., 1993) . Moreover, Ishibashi et al. (1994) showed that persistent expression of HES-1 in the telencephalon of mouse embryos inhibits neuronal development, resulting in a signi®cant loss of cortical neurons. The results of our TUNEL labeling studies showing that cellular apoptosis is increased in the telencephalon of Ta1:TLE1 transgenic embryos suggest that the expression of the Ta 1:TLE1 transgene may lead to increased neuronal apoptosis and loss of telencephalic neurons. It remains to be determined, however, whether the increase in apoptosis that was detected in the transgenic mice accounts for the full extent of the neuronal loss that accompanies the expression of the transgene.
The ®nding that TLE1 plays an important function during forebrain development is also signi®cant in light of the fact that the telencephalon is the largest and most complex region of the mammalian brain, particularly in primates. The dramatic expansion of the cerebral hemispheres from lower to higher species is an important feature of vertebrate evolution and is associated with an increased capacity to perform complex tasks and acquire higher cognitive functions. Little is currently known about the molecular mechanisms that control the development of the telencephalon. The present ®nding that TLE1 participates in telencephalic development, combined with the previous demonstration that TLE1 interacts with a number of transcription factors expressed during forebrain development (see below for further discussion), will now provide testable hypotheses that will facilitate the analysis of these complex mechanisms.
Possible molecular mechanisms of action of TLE1 during neuronal development
Our results demonstrate that different neuronal populations are not equally vulnerable to continuous TLE1 expression. In contrast to the forebrain, no abnormalities were detected in the spinal cord and peripheral nervous system, although the Ta1 promoter is robustly activated in these tissues (Gloster et al., 1999) . This argues against the possibility that the observed phenotype derives from a non-speci®c perturbation of postmitotic neuronal development, a situation that would likely result in widespread neuronal abnormalities. Instead, the restricted nature of the developmental defects suggests that deregulation of TLE1 activity interferes with the functions of proteins that play important roles in forebrain development. In other areas of the nervous system, these proteins may have less important roles or their functions may be less susceptible to changes in TLE1 expression. Such changes may be obscured if other TLE family members are expressed in patterns that complement the normal expression of TLE1, as seems to be the case in the caudal region of the brain and the spinal cord (Grbavec et al., 1998; Yao et al., 1998) .
Proteins whose functions may have been perturbed by the expression of the Ta 1:TLE1 transgene include the mammalian HES bHLH factors. TLE1 physically interacts with the HES family members, HES-1 and HES-5, and is coexpressed with the latter in the developing telencephalon (Akazawa et al., 1992; Sasai et al., 1992; Dehni et al., 1995; Grbavec et al., 1998; Yao et al., 1998; Casarosa et al., 1999) . This suggests that the phenotype observed in Ta1:TLE1 embryos may be mediated, at least in part, by interactions with HES-1 and/or HES-5. This possibility is consistent with the demonstration that disruption of HES-1 function in HES-1 2/2 mice perturbs development of the cerebral hemispheres but has little or no effect on the spinal cord and peripheral nervous system (Ishibashi et al., 1995) , a phenotype similar to that observed in Ta1:TLE1 transgenic embryos. Although HES-1 and HES-5 are predominantly expressed in neural progenitor cells, their expression was also detected in postmitotic neurons of the forebrain in which the Ta1 promoter is activated (Akazawa et al., 1992; Casarosa et al., 1999) . This suggests that the repressive functions of TLE1:HES complexes may be prolonged in Ta1:TLE1 transgenic mice, resulting in inhibition of the functions of genes that promote neuronal differentiation. The functions of HES and Groucho proteins during Drosophila neurogenesis and the demonstration that HES-1 can inhibit the activity of the promoter of the mammalian proneural gene, Hash-1 (Chen et al., 1997) , suggest that, during mammalian neurogenesis, complexes of HES and TLE1 proteins may negatively regulate the expression of proneural genes. In postmitotic telencephalic neurons, these may include the structurally related genes, NeuroD, NEX/Math2, and NDRF (Schwab et al., 1998) . The downregulation of NeuroD expression observed in Ta1:TLE1 embryos is in agreement with this hypothesis and raises the interesting possibility that repression of NeuroD (and/or other related proneural genes) may be a direct cause of the perturbation of neuronal differentiation in the forebrain of transgenic embryos. However, the correlative nature of our observations at this time does not allow us to distinguish whether NeuroD is a bona ®de target of TLE1 activity or whether its down-regulation is a result of the depletion of NeuroD-expressing cells.
It is also entirely possible that other DNA-binding proteins known to interact with TLE/Groucho proteins may mediate the effects associated with persistent TLE1 expression. In particular, TLE proteins have recently been implicated in the regulation of the functions of the TCF/LEF family of transcription factors, due to their ability to interact with and repress the transactivating function of the latter (Levanon et al., 1998; Roose et al., 1998) . Since members of the TCF/LEF family are expressed in the developing mammalian forebrain (Cho and Dressler, 1998) , alteration of TLE1 expression may affect functions performed by TCF/LEF proteins during brain development. Also, by analogy to the C. elegans Groucho homologue, UNC-37 (P¯ugrad et al., 1997) , it is possible that TLE proteins may interact with selected members of the homeodomain protein family and that these interactions may be important for regulating the differentiation of certain neuronal populations. Identifying cascades of events perturbed in Ta1:TLE1 transgenic embryos will facilitate the study of mechanisms important for neuronal development.
Experimental procedures
Generation of transgenic mice
A partially digested ,2.8 kb EcoRI fragment containing the entire coding sequence of human TLE1 (Stifani et al., 1992) was blunt-ended with Klenow DNA polymerase and subcloned into the previously described (Majdan et al., 1997) Ta1 promoter vector that had been digested with PstI and subjected to ®lling-in of protruding ends with Klenow DNA polymerase. The resulting construct contained ,1.1 kb of sequence from the Ta1 promoter and ,0.7 kb of sequence from the SV40 small T antigen intron and polyadenylation region, in addition to the TLE1 insert. The microinjection fragment was released from the cloning vector by digestion with BssHII, followed by gel electrophoresis to isolate the ,4.6-kb fragment. This fragment was injected into pronuclear stage embryos at a concentration of 4 ng/ml as described previously (Eyer and Peterson, 1994) . Injected embryos were transferred into pseudopregnant B6C3F1 females. Founder animals were identi®ed by subjecting genomic DNA isolated from tail biopsies to Southern blotting analysis as described below.
Genotype analysis
Genotyping was performed by subjecting DNA obtained from biopsies (tails of postnatal animals and tails or hindlimbs of embryos, depending on stage) to Southern hybridization analysis. Roughly 5 mg of EcoRI-digested DNA was subjected to gel electrophoresis, transferred to nylon membranes, and hybridization in the presence of a 32 P-labeled probe corresponding to the region of the human TLE1 cDNA encoding amino acids 260±435 (Stifani et al., 1992) . Hybridization and washing conditions were as described previously (Stifani et al., 1992) .
Histological analysis
Embryos were obtained from timed matings, ®xed in 4% paraformaldehyde, embedded in paraf®n, sectioned, and stained with hematoxylin and eosin as described previously (Dehni et al., 1995; Grbavec et al., 1998; Yao et al., 1998) . Immunohistochemical studies with af®nity puri®ed anti-TLE1 polyclonal antibodies (Husain et al., 1996; Yao et al., 1998) and anti-type III b-tubulin monoclonal antibodies (Geisert and Frankfurter, 1989) were performed as described previously. Preparation of sense and antisense riboprobes by transcription in the presence of digoxigenin 11 UTP and in situ hybridization experiments were performed as described (Dehni et al., 1995; Liu et al., 1996) . Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) analysis was performed using the Apoptag kit (Oncor), according to the manufacturer's instructions.
Western blotting analysis
Dissected embryonic tissues were rinsed and homogenized as described (Husain et al., 1996; Palaparti et al., 1997) . Equal amounts of proteins were subjected to SDS-PAGE and transfer to nitrocellulose, followed by staining with Ponceau S to verify that individual lanes contained equal amounts of proteins. Nitrocellulose replicas were incubated with anti-TLE1 antibodies (Husain et al., 1996; Yao et al., 1998) and then stripped and reprobed with a number of different antibodies, including anti-TLE4 polyclonal (Yao et al., 1998) , anti-NeuroD polyclonal (Santa Cruz Biotechnology), anti-NCAM 5B8 monoclonal (Dodd et al., 1988) , anti-Pax-6 polyclonal (Babco), anti-BF-1 polyclonal (a kind gift of Dr Eseng Lai, Memorial Sloan-Kettering Cancer Center, NY), anti-radial glial antigen 3CB2 monoclonal (Prada et al., 1995) , and anti-p55cdc (Santa Cruz Biotechnology) antibodies.
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